[Lymphotropic immune correction with myelopid in the postoperative period in patients with cancer of the colon and rectum].
An analysis of surgical treatment of 142 patients with cancer of the colon and rectum included 32 emergency cases and 110 scheduled operations. Standard surgical methods only were used in 94 patients, the lymphotropic immunocorrection with myelopidum in the postoperative period was made in 48 patients. The use of lymphotropic immunocorrection was shown to considerably improve the immunological parameters and to decrease postoperative lethality.
Cherkasov
V A
VA
Kevorkov
N N
NN
Kataev
V P
VP
Shilova
N A
NA
Shilov
Iu I
IuI
D000276:Adjuvants, Immunologic / Q000008:administration & dosage*; D000328:Adult; D000367:Age Factors; D000368:Aged; D003082:Colectomy; D015179:Colorectal Neoplasms / Q000276:immunology / Q000401:mortality / Q000601:surgery*; D003125:Colostomy; D003627:Data Interpretation, Statistical; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009842:Oligopeptides / Q000008:administration & dosage*; D011184:Postoperative Period; D012737:Sex Factors
D000276:Adjuvants, Immunologic; D009842:Oligopeptides; C048617:myelopeptides